Please use this identifier to cite or link to this item: https://doi.org/10.1358/mf.1999.21.3.534831
Title: The efficacy and safety of eperisone in patients with cervical spondylosis: Results of a randomized, double-blind, placebo-controlled trial
Authors: Bose, K. 
Keywords: Cervical spondylosis
Controlled clinical trial
Eperisone
Issue Date: 1999
Source: Bose, K. (1999). The efficacy and safety of eperisone in patients with cervical spondylosis: Results of a randomized, double-blind, placebo-controlled trial. Methods and Findings in Experimental and Clinical Pharmacology 21 (3) : 209-213. ScholarBank@NUS Repository. https://doi.org/10.1358/mf.1999.21.3.534831
Abstract: A randomized, double-blind, clinical trial was undertaken to assess the activity of eperisone hydrochloride (50 mg t.i.d.), a commonly used muscle relaxant, as a treatment for cervical spondylosis in 157 patients. The results showed a clear benefit of eperisone treatment with regard to pain in the nuchal region, back pain, pain in arms and shoulders, stiffness and other symptoms of cervical spondylosis, while the tolerability of the treatment was optimal.
Source Title: Methods and Findings in Experimental and Clinical Pharmacology
URI: http://scholarbank.nus.edu.sg/handle/10635/133835
ISSN: 03790355
DOI: 10.1358/mf.1999.21.3.534831
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

16
checked on Jan 16, 2018

WEB OF SCIENCETM
Citations

14
checked on Dec 5, 2017

Page view(s)

5
checked on Jan 20, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.